In this Pharmaceutical Executive interview, Daniela Marino, PhD, Co-founder and CEO of CUTISS, talks about her involvement in supporting the development of denovoSkin™, an autologous, bio-engineered ...

Excluding scientific research, this was the first time that a patient this young has been treated with the new method called DenovoSkin. The Maasstad Ziekenhuis had performed clinical tests on the new ...

Global visionaries special: Dr Daniela Marino, CEO of Cutiss. Dr Daniela Marino is the CEO and co-founder of skin-graft innovators Cutiss and one of the inspirational leaders that UBS supports and ...

Dr Daniela Marino is the CEO and co-founder of skin-graft innovators Cutiss and one of the inspirational leaders that UBS supports and celebrates through its Global Visionaries programme. Marino is ...

CVC CHAGRIN. Chagrin Falls. Coach: Dave Bargar, 20th year. Last year: 10-15 (3-5) D-III district semifinals. OHSAA: Division V. Roster: Spencer Kaas, 6-1, Sr., G ...

Marino, the Cutiss CEO, told the Globe that the treatment also aims to reduce scarring for burn victims, which would prevent complications and reduce the need for further reconstructive procedures.

Switzerland also has cutting-edge medical technology and a prime example of this is Cutiss AG, which is manufacturing skin. Grown in a lab, the skin is meant to help burn victims and other people ...

Cutiss, a Swiss clinical-stage life sciences company, develops regenerative medicine and skin tissue engineering therapies. The company’s lead product is a personalized skin graft called denovoSkin.

Human skin cells provided by Dr. Marjana Tomic-Canic, director of the Wound Healing and Regenerative Medicine Research Program at the Miller School of Medicine, were launched to the International ...

Human skin cells provided by Marjana Tomic-Canic, director of the Wound Healing and Regenerative Medicine Research Program at the Miller School of Medicine, were launched to the International Space ...